ZEB1 and T-cell non-Hodgkin lymphoma: ZEB1 mutant mice confirmed the importance of this alteration by frequently developing invasive CD4+ T-cell lymphomas; additional in vitro studies showed the loss of ZEB1 expression in ATLL cells resulted in an escape from growth inhibition by TGF-β.